Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



The efficacy of novel heterocyclic activators against mercuric chloride-induced acute renal failure in rats

Safaa H. Mohamed, Dina S. El-kady, Gamal A. Elmegeed, Mahitab I. El-kassaby, Abdel-Razik H. Farrag, Mervat M Abdelhalim, Naglaa A. Ali.




Abstract
Cited by 2 Articles

Mercury chloride (HgCl2) has a potent nephrotoxic effect. Synthesizing new heterocyclic steroids using some chemical strategies could be predictable to have promising efficiency against mercuric chloride-induced acute renal failure. Analytical and spectral data affirmed the structure of the unprecedented heterocyclic steroids. To assess their biological activities, rats were treated with tested compounds after HgCl(2) intraperitoneally injected, daily treatment for another month. In comparison with HgCl(2) group. Synthesized compounds significantly prevented increased serum levels of creatinine, urea, renal lipid peroxidation, and NO levels, decreasing serum GOT, GPT, ALP, TNF-α, and IL-1 β levels and lipid profile concentration, and showed a significant increase in HDL and CAT levels. They moreover, upregulated levels of Nephrin-2 and KIM-1 Genes Expression. Histopathological results supported our biochemical findings. Noteworthy, compounds 6 and 9 in particular, have more antioxidant and anti-inflammatory activities than compounds 4 and 5 and play a salutary role against HgCl2 toxicity. The biological characteristics of these new generations of heterocyclic steroid derivatives, which are demonstrated by their anti-inflammatory and antioxidant properties, could serve as a useful framework for the continued development of potent therapeutics.

Key words: Heterocyclic, Steroids, Mercuric chloride, Kidney injury, Inflammation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.